Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib in PALB2-mutated metastatic breast cancer
NCT05232006Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of niraparib in breast cancer, sponsored by Assistance publique - Hôpitaux de Paris. Planned start May 2022; status: not yet recruiting.
02
Drugs
niraparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05232006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232006.